AAP
AMLX icon

Arax Advisory Partners’s Amylyx Pharmaceuticals AMLX Stock Holding History

Arax Advisory Partners’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.1K Buy
2,235
+741
+50% +$11.5K ﹤0.01% 3453
2026
Q1 		$20.8K Sell
1,494
-1,056
-41% -$14.9K ﹤0.01% 2094
2025
Q4 		$30.8K Buy
2,550
+306
+14% +$4.16K ﹤0.01% 1877
2025
Q3 		$30.5K Buy
+2,244
New +$21.1K ﹤0.01% 2075
2025
Q1 		– Sell
-2,193
Closed -$8.29K – 2681
2024
Q4 		$8.29K Hold
2,193
– – ﹤0.01% 1553
2024
Q3 		$7.11K Hold
2,193
– – ﹤0.01% 1555
2024
Q2 		$4.17K Buy
+2,193
New +$4.25K ﹤0.01% 1673

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Arax Advisory Partners's AMLX Position: Q2 2026 in Review

Arax Advisory Partners increased its Amylyx Pharmaceuticals (AMLX) stake by 50% in Q2 2026, buying an estimated $11.5K and bringing the position to 2,235 shares worth $40.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3453.

Arax Advisory Partners first reported a position in AMLX in Q2 2024 and has held it in 7 quarters since. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • Arax Advisory Partners held 2,235 shares of Amylyx Pharmaceuticals worth $40.1K as of Q2 2026.
  • Arax Advisory Partners bought 741 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $11.5K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3453 holding.
  • Arax Advisory Partners first reported a position in Amylyx Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.